Allergan’s portfolio features best-in-class facial aesthetics, body contouring, plastic surgery and regenerative medicine offerings, which includes products such as BOTOX Cosmetic®, CoolSculpting®, Natrelle® and more.
Piper Jaffray (NYSE: PJC) is a leading investment bank focused on mergers and acquisitions, public offerings, public finance, institutional brokerage, investment management and research. Founded in 1895, the firm is headquartered in Minneapolis with offices across the U.S. and in London, Aberdeen, Zurich and Hong Kong.
Revance® is a proud sponsor of the Aesthetics Innovation Summit (AIS), and an emerging biotechnology leader in aesthetic medicine and therapeutic specialties. Revance® is actively pursuing new ways to advance the neuromodulator product category through the development of the first innovative neuromodulator product in nearly 30 years: daxibotulinumtoxinA for Injection (DAXI). DAXI combines a highly purified botulinum toxin type A molecule, with a proprietary stabilizing excipient peptide technology, to produce the first long-acting injectable neuromodulator formulated without human serum albumin.
Combining Revance’s unique peptide technology with DAXI may help address currently unfulfilled needs in aesthetic medicine and in several therapeutic indications. Given the number of indication areas in clinical development, the company’s daxibotulinumtoxinA compound is often referred to as “a pipeline within a product.”
In the Phase 3 SAKURA clinical trials, DAXI achieved unrivaled efficacy, including a median 24-week duration of effect in treating glabellar lines. Revance is creating a new neuromodulator category and will redefine the value of enduring results that resonate with today’s consumer.
“Our goal is to be innovative pioneers in neuromodulators. The clinical data from multiple clinical trials supports the potential for DAXI to be a differentiated injectable neuromodulator capable of delivering clinical efficacy for a median of 24 weeks. We see a growing demand from physicians and consumers for a long-acting neuromodulator, and look forward to continuing to work toward bringing to market a premium brand that is distinct from the current commercially available products.“
~ Dan Browne, Co-Founder, President and CEO
DaxibotulinumtoxinA is an investigational agent that has not been approved by the FDA. Revance anticipates commercial launch in 2020 upon FDA approval.
Aesthetics Biomedical is committed to the development and distribution of innovative aesthetic devices, products, and services for the global market. We create novel patient treatment experiences that ensure our products yield desired results, keeping patient comfort in mind. We also deliver state-of-the-art training to guarantee the best possible outcomes for providers and patients.
ALASTIN Skincare, Inc. is a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products with proprietary TriHex Technology® that enhance, protect, and maintain healthy skin for a lifetime. In addition to its award-winning daily skin care line, Alastin Skincare has created a new category in the aesthetic space with its leading line of procedure products that prepare skin for rejuvenating procedures, help skin heal after procedures, and optimize the patient experience and outcomes.
Endo Aesthetics™ is a unit of Endo Pharmaceuticals Inc., a specialty branded pharmaceutical company with over 20 years of experience. Driven by world-class research and development, Endo is committed to creating the aesthetic solutions of tomorrow through the development of a new, scientifically different treatment for cellulite. Endo Aesthetics™ is headquartered in Malvern, PA.
MTF Biologics serves Plastic & Reconstructive Surgeons in breast reconstruction, craniofacial procedures, burns and other traumatic injuries, while providing solutions in breast, body and facial cosmetic procedures. We support General Surgeons in abdominal wall reconstruction, hernia repair and gastrointestinal procedures. MTF Biologics Plastic & Reconstructive Surgery meets the needs of surgeons so that they can provide the best care for their patients. We save and heal lives.
Dermira is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology. We are focused on delivering important new therapies to the millions of patients living with chronic skin conditions.
Dermira is committed to understanding and addressing the needs of both patients and physicians. We are using our experience and insight to identify and develop leading-edge medical dermatology clinical programs. Our goal is to help transform the way skin conditions are treated by serving as the bridge between unmet patient needs and the significant scientific advances being made in understanding skin biology.
HintMD offers a dynamic subscription payments platform to transform some of the most complicated aspects of patient interactions into highly satisfying experiences for the patient and the practice. We seamlessly automate and simplify loyalty programs to create better outcomes for patients and increase retention for aesthetic practices.
Merz in the Americas
Merz has a direct presence in six countries in the Americas, as well as a network of selected professional distribution partners in South and Central America and the Caribbean. Merz in the Americas is headquartered in Raleigh, North Carolina, and has facilities in Mesa, Arizona, Franksville, Wisconsin as well as offices in Toronto, Canada, Mexico City, Bogotá, Colombia, São Paolo, Brazil and Buenos Aires, Argentina. For more information, visit www.merzusa.com.
Virtual Health Partners
Virtual Health Partners (VHP) is an innovator in health and wellness, focusing on live virtual nutrition, fitness and lifestyle modification within a contained ecosphere of support. Offered exclusively through a network of participating partners, including Physicians, Medi-Spas, Fitness, Insurance, Health & Wellness, Medical Device, Pharmaceutical and Nutrition Supplement Companies, the Company's Business-to Business-to-Consumer (B2B2C) model provides a SaaS and PaaS solution that is fully scalable and cost-effective. Through a proprietary Privacy and HIPAA compliant platform, VHP is able to provide a turn-key virtual solution for its business partners across various verticals including aesthetics, fitness, plastic surgery, wellness, weight loss.
Dermatology Times provides relevant clinical, aesthetic, and business information to dermatologists and other skin care specialists. Our unbiased and timely content is written in an easy-to-read format and is available in print, online, and mobile.
Modern Aesthetics® magazine delivers expert advice on patient care and practice development for core aesthetic physicians. With content by and for clinicians, each edition offers unique perspectives and pearls, while reporting the latest developments in minimally-invasive aesthetics—from skincare to advanced procedures. Leaders from the core specialties help clinicians successfully integrate new technologies into practice by sharing success strategies.
NewBeauty is the Beauty Authority. Our mission is to inspire, educate and guide women to make smart, informed and confident beauty choices. NewBeauty delivers cutting-edge information on the latest technologies, advanced beauty solutions, breakthrough products, cosmetic enhancement procedures and leading professionals as well as advancements in wellness, fitness, and nutrition. Our powerful editorial content and expert-approved advice fill a void where in-depth, unbiased and trusted information is impossible to find.